Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
P05093
UPID:
CP17A_HUMAN
Alternative names:
17-alpha-hydroxyprogesterone aldolase; CYPXVII; Cytochrome P450 17A1; Cytochrome P450-C17; Steroid 17-alpha-monooxygenase
Alternative UPACC:
P05093; Q5TZV7
Background:
Steroid 17-alpha-hydroxylase/17,20 lyase, also known as Cytochrome P450 17A1 or CYPXVII, plays a pivotal role in corticoid and androgen biosynthesis. It catalyzes crucial steps in the production of cortisol and androgens, including 17-alpha hydroxylation and acyl-carbon cleavage, essential for adrenal glucocorticoids and estriol synthesis.
Therapeutic significance:
The protein's malfunction is linked to Adrenal hyperplasia 5, a congenital condition characterized by defective cortisol synthesis, leading to androgen excess and various developmental issues. Understanding the role of Steroid 17-alpha-hydroxylase/17,20 lyase could open doors to potential therapeutic strategies for this and related disorders.